Capitol Health (CAJ) runs close to price target
Morgans
Capitol Health (CAJ) runs close to price target. Capitol Health (CAJ, Hold, Price Target A$1.11) CAJ has had a strong share price run since its recent capital raising in December and subsequent acquisitions. CAJ's entry into the NSW radiology market with the acquisition of Southern Radiology is seen a sensible and logical move to expand its footprint. With the share price within 10% of our price target we have moved back to a Hold. Report here: (VIEW LINK) @morgans
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise